YMT Co Ltd

YMT Co Ltd maintains a capital structure with a debt-to-equity ratio of 0.69, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.47, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints.

Profitability metrics for YMT Co Ltd are weak, with a return on equity (ROE) of -4.09% and a return on assets (ROA) of -1.88%. These figures fall significantly below the typical performance benchmarks for the specialty chemicals industry, indicating underperformance in generating returns for shareholders and asset utilization.

The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no material geographic diversification. This lack of diversification increases exposure to sector-specific risks and regional economic fluctuations.

YMT Co Ltd's growth trajectory is mixed. While the company reported a revenue of KRW 34,813,433,880 in the latest period, its net income was negative at KRW -4,883,697,390. The outlook for the current fiscal year suggests a continuation of this trend, with no significant improvement in revenue or profitability expected in the near term.

The company faces several risk factors, including a weak liquidity position and a negative net cash position. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company has not disclosed any imminent plans for share dilution, and its diluted shares outstanding remain unchanged at 17,383,915.

Recent filings and transcripts do not indicate any major strategic shifts or operational changes. The company's capital expenditure of KRW -16,494,912,730 and free cash flow of KRW -7,770,766,650 suggest that the company is investing heavily in its operations, but these investments have not yet translated into positive returns.

Operating income surged 204.2% year-over-year to 13.06 billion KRW, signaling a strong recovery in core profitability.

Net income improved by 61.2% year-over-year, narrowing the loss to 1.68 billion KRW in the latest period.

Free cash flow improved by 40.0% year-over-year, reducing the cash burn to 18.04 billion KRW.

Gross profit reached 39.04 billion KRW in the latest period, indicating resilient top-line pricing power.

Revenue grew 5.4% year-over-year to 144.6 billion KRW, demonstrating consistent top-line expansion despite market headwinds.

The company carries a high credit risk flag, suggesting significant concerns regarding its ability to meet debt obligations.

Debt-to-equity ratio stands at 0.69, significantly higher than the 0.23 median for the Specialty Chemicals cohort.

Return on equity is negative at -4.09%, falling into the bottom quartile versus the 3.93% cohort median.

Cash conversion ratio is -0.29, ranking in the bottom quartile compared to the 1.08 cohort median.

Revenue KRW 127.41B, −2,4% YoY; Operating income −199,1% YoY.

• ▍Revenue KRW 127.41B, −2,4% YoY
• ▍Operating income −199,1% YoY
• ▍Net income −5 443,5% YoY
• ▍Free cash flow −43,5% YoY
• ▍Net margin -2.3%

Revenue KRW 130.57B, +4,0% YoY; Operating income −81,1% YoY.

• ▍Revenue KRW 130.57B, +4,0% YoY
• ▍Operating income −81,1% YoY
• ▍Net income −100,5% YoY
• ▍Free cash flow −502,1% YoY
• ▍Net margin -0.0%

Revenue KRW 125.57B; Operating income KRW 16.88B.

• ▍Revenue KRW 125.57B
• ▍Operating income KRW 16.88B
• ▍Net margin 7.7%